Genetic cancer vaccines: current status and perspectives.
about
The Promise of Preventive Cancer VaccinesTherapeutic cancer vaccines: past, present, and futureERBB3: A potential serum biomarker for early detection and therapeutic target for devil facial tumour 1 (DFT1)A novel minigene scaffold for therapeutic cancer vaccinesSuperior Immunologic and Therapeutic Efficacy of a Xenogeneic Genetic Cancer Vaccine Targeting Carcinoembryonic Human Antigen.Phase 1 studies of the safety and immunogenicity of electroporated HER2/CEA DNA vaccine followed by adenoviral boost immunization in patients with solid tumors.Safety and efficacy of a genetic vaccine targeting telomerase plus chemotherapy for the therapy of canine B-cell lymphomaAdenovirus: the first effective in vivo gene delivery vectorImmunogenicity and therapeutic efficacy of a dual-component genetic cancer vaccine cotargeting carcinoembryonic antigen and HER2/neu in preclinical models.Electro-gene-transfer as a new tool for cancer immunotherapy in animals.Cancer vaccination by electro-gene-transfer.Preclinical vaccines against mammary carcinoma.Xenogene vaccination in the therapy of cancer.Antigen-specific vaccines for cancer treatment.Large-scale adenovirus and poxvirus-vectored vaccine manufacturing to enable clinical trials.Adenoviral vector delivery of RNA-guided CRISPR/Cas9 nuclease complexes induces targeted mutagenesis in a diverse array of human cells.Immunotherapy of cancers comes of age.Adenovirus-Mediated Gene Delivery: Potential Applications for Gene and Cell-Based Therapies in the New Era of Personalized Medicine.Cancer Vaccines in Ovarian Cancer: How Can We Improve?Immunooncology in Breast Cancer: Active and Passive Vaccination Strategies
P2860
Q26783742-0E2805DE-03AD-47FA-9195-B9C45DCF0EFBQ26863283-A0C321BB-A45B-40D0-9AD5-09EBEB92F46FQ33772914-8BBB0D8C-4817-4AD4-B7AD-2BBC2B648728Q34418540-EF592FC4-E340-46C1-94C0-CA08B9611DE4Q35822301-0ECA0B7F-2FB8-4145-9E79-B4DF36719020Q36690209-F3B59EE6-3B97-4464-ADEE-6364DA99FE11Q37101956-04EF63E1-2222-45A5-AF3D-4578EC7229BDQ37508260-6F69E62F-0EF4-478D-803D-0365701917ADQ37580312-317F88F6-1607-4C9A-9F66-F3E5A1B7D0E4Q38055259-D41F5D4C-35E0-4281-A163-52D7D19B73E4Q38143182-9280AA78-2064-4B0D-A33A-071A36F18F9CQ38160252-942A34EC-6402-4064-9EFB-106679143D94Q38229368-1BB56903-D4F4-46F9-88A4-CB322D59521DQ38284692-2877ABB5-2474-41AD-AACF-CFE0556D1E50Q38443390-8192D6DB-BA67-406E-9A89-BD84B7BD7B17Q40033479-FFB87CB3-62A1-48AA-8C71-9664D0F9B507Q40099075-3AB27154-77C0-4407-AE52-E281FFC57E41Q41699782-112CD00E-F3AC-4D4B-8D47-EC2F6449E827Q54385315-2913709B-A1BE-40E4-87BE-ECE2ABFACE8EQ57114269-7EA3A405-305B-45EA-AF3C-A1EA9CB091D9
P2860
Genetic cancer vaccines: current status and perspectives.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Genetic cancer vaccines: current status and perspectives.
@en
type
label
Genetic cancer vaccines: current status and perspectives.
@en
prefLabel
Genetic cancer vaccines: current status and perspectives.
@en
P2860
P1476
Genetic cancer vaccines: current status and perspectives
@en
P2093
Luigi Aurisicchio
P2860
P304
P356
10.1517/14712598.2012.689279
P407
P577
2012-05-12T00:00:00Z